Gilead Sciences Inc.



Before the Bell

 --Quotes are delayed by 20 min

Mar 28, 2023, 8:02 a.m.





0.00 0.00%


Volume 546

Quotes are delayed by 20 min


Previous close

$ 79.58

$ 79.58


-0.42 -0.53%

Day low

Day high




52 week low

52 week high




Annual Financials for Gilead Sciences Inc.

Fiscal year is January-December. All values USD millions. 20182019202020212022 5-year trend
Sales/Revenue 22.21B22.32B24.64B27.37B27.09B
Cost of Goods Sold (COGS) incl. D&A 4.85B4.68B4.51B6.6B5.66B
COGS excluding D&A 3.42B3.27B3.03B4.55B3.55B
Depreciation & Amortization Expense 1.43B1.4B1.48B2.05B2.1B
Depreciation 226M255M288M329M323M
Amortization of Intangibles 1.2B1.15B1.19B1.72B1.78B
Gross Income 17.36B17.65B20.13B20.77B21.43B
20182019202020212022 5-year trend
SG&A Expense 8.25B12.69B9.69B10.57B10.67B
Research & Development 4.2B8.31B4.86B5.36B5B
Other SG&A 4.06B4.38B4.83B5.21B5.67B
Other Operating Expense -----
Unusual Expense 707M(422M)2.94B1.52B4.21B
EBIT after Unusual Expense 8.4B5.38B7.5B8.68B6.54B
Non Operating Income/Expense 476M773M(4.85B)600M205M
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense 1.08B995M984M1B935M
Gross Interest Expense 1.08B995M984M1B935M
Interest Capitalized -----
Pretax Income 7.8B5.16B1.67B8.28B5.81B
Income Tax 2.34B(204M)1.58B2.08B1.25B
Income Tax - Current Domestic 1.88B1.78B1.65B2B2.57B
Income Tax - Current Foreign 175M124M155M185M232M
Income Tax - Deferred Domestic 307M(885M)(261M)(65M)(1.66B)
Income Tax - Deferred Foreign (21M)(1.22B)38M(47M)101M
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 5.46B5.36B89M6.2B4.57B
Minority Interest Expense 5M(22M)(34M)(24M)(26M)
Net Income 5.46B5.39B123M6.23B4.59B
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 5.46B5.39B123M6.23B4.59B
Preferred Dividends -----
Net Income Available to Common 5.46B5.39B123M6.23B4.59B
EPS (Basic)
Basic Shares Outstanding 1.3B1.27B1.26B1.26B1.26B
EPS (Diluted)
Diluted Shares Outstanding 1.31B1.28B1.26B1.26B1.26B
EBITDA 10.54B6.36B11.92B12.25B12.86B
Link to MarketWatch's Slice.